Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Table of contents

October 2003 - Volume 52 - 10

Gut: 52 (10)

Commentaries

Nutritional therapy for cancer cachexia (11 September, 2003)
R F Grimble
Origins of cardiac dysfunction in cirrhosis (11 September, 2003)
W Jiménez, V Arroyo
Transplanting the genetic susceptibility to Crohn’s disease (11 September, 2003)
M H Holtmann, M F Neurath

Digest

Digest (11 September, 2003) Free
Robin Spiller

Oesophagus

Effect of the GABA_B agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors
(11 September, 2003)
G H Koek, D Sifrim, T Lerut, J Janssens, J Tack

Stomach

Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial (11 September, 2003)
P W Y Chiu, C Y W Lam, S W Lee, K H Kwong, S H Lam, D T Y Lee, S P Y Kwok
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner
(11 September, 2003)
J R Bebb, D P Letley, R J Thomas, F Aviles, H M Collins, S A Watson, N M Hand, A Zaitoun, J C Atherton
Role of cognitive factors in symptom induction following high and low fat meals in patients with functional dyspepsia (11 September, 2003)
C Feinle-Bisset, B Meier, M Fried

Small intestine

Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial (11 September, 2003)
N H Alam, H Ashraf, W A Khan, M M Karim, G J Fuchs
Scavenger receptor class B type I (SR-BI) in pig enterocytes: trafficking from the brush border to lipid droplets during fat absorption (11 September, 2003)
G H Hansen, L-L Niels-Christiansen, L Immerdal, E M Danielsen

Inflammation and inflammatory bowel disease

Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001 (11 September, 2003)
H Hildebrand, Y Finkel, L Grahnquist, J Lindholm, A Ekbom, J Askling
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients (11 September, 2003)
S Danese, J A Katz, S Saibeni, A Papa, A Gasbarrini, M Vecchi, C Fiocchi
Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E₁ and E₂ production by intestinal myofibroblasts
(11 September, 2003)
L E M Willemsen, M A Koetsier, S J H van Deventer, E A F van Tol
Inducible CD40 expression mediates NFκB activation and cytokine secretion in human colonic fibroblasts (11 September, 2003)
C M Gelbmann, S N Leeb, D Vogl, M Maendel, H Herfarth, J Schölmerich, W Falk, G Rogler
Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse (11 September, 2003)
G Barbara, R De Giorgio, V Stanghellini, R Corinaldesi, C Cremon, N Gerard, C Gerard, E F Grady, N W Bunnett, P A Blennerhassett, S M Collins

Colon

The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development
(11 September, 2003)
C Bonhomme, I Duluc, E Martin, K Chawengsaksophak, M-P Chenard, M Kedinger, F Beck, J-N Freund, C Domon-Dell
Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells (11 September, 2003)
H Sheng, J Shao, C M Townsend, B M Evers
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial (11 September, 2003)
K C H Fearon, M F von Meyenfeldt, A G W Moses, R van Geenen, A Roy, D J Gouma, A Giacosa, A Van Gossum, J Bauer, M D Barber, N K Aaronson, A C Voss, M J Tisdale

Pancreas

Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis (11 September, 2003)
N Ohnishi, T Miyata, H Ohnishi, H Yasuda, K Tamada, N Ueda, H Mashima, K Sugano

Liver

Mutations in SRD5B1 (AKR1D1), the gene encoding Δ⁴-3-oxosteroid 5β-reductase, in hepatitis and liver failure in infancy
(11 September, 2003)
H A Lemonde, E J Custard, J Bouquet, M Duran, H Overmars, P J Scambler, P T Clayton
Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy (11 September, 2003)
C Skipper, J M Guy, J Parkes, P Roderick, W M Rosenberg
Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation (11 September, 2003)
R B Vaughan, P W Angus, J P F Chin-Dusting
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease (11 September, 2003)
J H Henriksen, J P Gøtze, S Fuglsang, E Christensen, F Bendtsen, S Møller

Case report

Fulminant Crohn’s colitis after allogeneic stem cell transplantation (11 September, 2003)
S A Sonwalkar, R M James, T Ahmad, L Zhang, C S Verbeke, D L Barnard, D P Jewell, M A Hull

Review

The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria (11 September, 2003)
A J Stagg, A L Hart, S C Knight, M A Kamm

Letters

Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines (11 September, 2003)
R F Logan, T P van Staa
Worsening of steatosis and fibrosis progression in hepatitis C (11 September, 2003)
L Castéra, J-M Pawlotsky, D Dhumeaux
Complete regression of advanced HCC with long acting octreotide (11 September, 2003)
J T Siveke, C Folwaczny, C Herberhold
Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy (11 September, 2003)
K Schulmann, S Hollerbach, W Schmiegel
Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C (11 September, 2003)
T Poynard
Risk of fracture in coeliac disease (11 September, 2003)
R Logan, J West

Issue Information